Sanjeev Redkar

@sanjeevredkar

Biotech Pharma executive, Actor, Runner Apollomics Inc, President & CoFounder

San Francisco
Vrijeme pridruživanja: kolovoz 2009.

Tweetovi

Blokirali ste korisnika/cu @sanjeevredkar

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @sanjeevredkar

  1. prije 13 sati

    Great initiatives by workshop on for 2025 . Project for concurrent approvals; Project for label expansion of generics; Project for expanded access for cancer ; Project for longitudinal PROs.

    Poništi
  2. proslijedio/la je Tweet

    On this , I'm proud to reflect on the work does every day to strengthen and cancer control activities around the world.

    Poništi
  3. 3. velj

    The John's Hopkins site updates numbers evening US times, so the same graph in morning in US looks like it is changing direction, but once updated in evening it seems not yet reached

    Poništi
  4. 3. velj

    All BTD applications should be under FOI. That way one can see which ones do not meet the bar.

    Poništi
  5. 2. velj

    For the first time, the incidence curve is changing slopes indicating . Jan 23 was the Wuhan lockdown. Up to 14 days incubation means cure to continue downward after Feb 6!

    Poništi
  6. proslijedio/la je Tweet
    29. sij

    This is the sharpest movie of the Sun ever made. Even at this fine resolution, the scale is enormous; each plasma cell here is about the size of Texas. via

    Prikaži ovu nit
    Poništi
  7. 29. sij

    Congratulations . Best wishes for your new journey at PwC.

    Poništi
  8. proslijedio/la je Tweet
    29. sij

    Largest clinical data set from initial cases of just published online at Includes 99 patients with , 49 (49%) had a history of exposure to the Huanan seafood market. 11% died, 31% discharged so far.

    Poništi
  9. proslijedio/la je Tweet
    27. sij

    China reports confirmed cases +39% to total 2744; Death toll +43% to total 80 With spreading to >10 countries in 4 continents, only sensible for to declare PHEIC now. Over-reaction better than under-reaction at this pt!

    Poništi
  10. proslijedio/la je Tweet
    23. sij

    Pro tip (academia or life): if what you’re doing requires setting up a new offshore bank account, you may not want to do what you’re about to do

    Poništi
  11. proslijedio/la je Tweet
    20. sij

    Why do some lung cancer patients respond to immunotherapy while others do not? Multimodal genomic features recently published in Nature Cancer may help identify patients that benefit most from immune checkpoint blockade.

    Poništi
  12. proslijedio/la je Tweet
    15. sij

    I'm sharing some of my top book recommendations from 2019, along with my ranking 1-10. Some of them are new, others I have read multiple times over the years.

    Prikaži ovu nit
    Poništi
  13. 13. sij

    How do these guys know it was yours ? US or China? Isn’t it locked?

    Poništi
  14. 12. sij

    ⁩ in a fireside chat with ⁦⁩. Inspiring story of Marianne making a difference in medicine despite challenges.

    Poništi
  15. 12. sij
    Poništi
  16. 12. sij

    Public vs Private session at Massimo Radaelli Athena Countouriotis and Simeon George - As private Co, you can have stretch goals; As a public Co, you need to underpromise and overdeliver.

    Poništi
  17. proslijedio/la je Tweet

    In 2019, FDA’s Center for Drug Evaluation and Research (CDER) approved a wide variety of new drug therapies to help patients in need. Check out our annual New Drug Therapy Approvals report to learn more: .

    Poništi
  18. 6. sij

    Apollomics licenses a late stage E-selectin antagonist that has received breakthrough designation for R/R AML for the Greater China region. Excited about partnering with Glycomimetics team on this program to bring this treatment to…

    Poništi
  19. proslijedio/la je Tweet
    5. sij
    Poništi
  20. proslijedio/la je Tweet
    4. sij

    Join us Feb 5 at FDA or online for FDA Oncology Center of Excellence Update: Envisioning Oncology and Product Development for 2025. Registration:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·